EN
HI
Summary
As of 22 Sep, 2026, Beta Drugs stock price is ₹2074.6. During the trading session, the stock has moved between an intraday low of ₹2033.90 and an intraday high of ₹2089.80. Over the last 52 weeks, Beta Drugs has traded between ₹990.10 and ₹2807.90.
The stock has recorded a trading volume of 10,479 shares,. Its Average Traded Price (ATP) is ₹2066.03, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2074.60.
Beta Drugs has an upper circuit limit of ₹2466.20 and a lower circuit limit of ₹1644.20. The total value traded stands at ₹2.16 CR, and the delivery percentage for the day is 55.49%.
The stock is currently traded with a market lot size of 1. Beta Drugs also offers a dividend yield of 0%.
Beta Drugs Share Price Chart
Beta Drugs Share Key Metrics
Volume
10479.00
Market Cap
2299.88 CR
LTQ@LTP
1@2074.60
ATP
2066.03
Var Margin
100 %
Circuit Range
1644.2-2466.2
Delivery %
55.49 %
Value
2.16 CR
ASM/GSM
No
Market Lot
1
Beta Drugs Fundamentals
P/E Ratio
55.1
P/B Ratio
5.44
Div. Yield
0
Sector P/E
42.35
Sector P/B
3.61
Sec. Div. Yield
0.51
Beta Drugs Resistance and Support
Pivot 2076.03
Resistance
First Resistance
2127.06
Second Resistance
2198.93
Third Resistance
2249.96
Support
First Support
2004.16
Second Support
1953.13
Third Support
1881.26
Beta Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Sep 21 2026 | 2053 | 2074.6 | 0.94% | 2089.8 | 2033.9 |
| Fri Sep 18 2026 | 2095.19 | 2055.19 | -1.90% | 2147.89 | 2025 |
| Thu Sep 17 2026 | 2054.6 | 2095 | 1.46% | 2112.39 | 2054.6 |
Beta Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-03 | Other business matters |
| 2026-07-20 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2026-01-09 | Others |
Beta Drugs Management
| Name | Position |
|---|---|
| Rahul Batra | Chairman & Managing Director |
| Varun Batra | Joint Managing Director |
Beta Drugs Similar Stocks
Dishman Carbogen Amcis Ltd.
170.50
-0.02 (0.01%)
Sakar Healthcare Ltd.
1158.45
-21.35 (1.81%)
Dr Agarwals Eye Hospital Ltd.
5280.50
-91.00 (1.69%)
Shukra Pharmaceuticals Ltd.
55.33
-0.60 (1.07%)
Indoco Remedies Ltd.
257.59
8.58 (3.45%)
Windlas Biotech Ltd.
1129.40
19.95 (1.80%)
Panacea Biotec Ltd.
376.15
8.25 (2.24%)
Sai Parenteral's Ltd.
510.85
0.10 (0.02%)
Fredun Pharmaceuticals Ltd.
1348.20
44.70 (3.43%)
Venus Remedies Ltd.
1593.20
0.00 (0.00%)
Beta Drugs FAQs
The Buying Price of Beta Drugs share is 2074.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Beta Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beta Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Beta Drugs shares is 55.1. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Beta Drugs shares is 5.44. Useful to assess the stock's value relative to its book value.
To assess Beta Drugs’s valuation compare Sector P/E, P/B which are 42.35 & 3.61 with sector averages, along with growth rates and financial metrics.
The Market Cap of Beta Drugs is 2299.88 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Beta Drugs share price is 2807.90 & 990.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Beta Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BETA
